| First Author | Federico G | Year | 2016 |
| Journal | JCI Insight | Volume | 1 |
| Issue | 1 | Pages | e84916 |
| PubMed ID | 27699213 | Mgi Jnum | J:237772 |
| Mgi Id | MGI:5816776 | Doi | 10.1172/jci.insight.84916 |
| Citation | Federico G, et al. (2016) Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis. JCI Insight 1(1):e84916 |
| abstractText | Renal tubular atrophy and interstitial fibrosis are common hallmarks of etiologically different progressive chronic kidney diseases (CKD) that eventually result in organ failure. Even though these pathological manifestations constitute a major public health problem, diagnostic tests, as well as therapeutic options, are currently limited. Members of the dickkopf (DKK) family, DKK1 and -2, have been associated with inhibition of Wnt signaling and organ fibrosis. Here, we identify DKK3 as a stress-induced, tubular epithelia-derived, secreted glycoprotein that mediates kidney fibrosis. Genetic as well as antibody-mediated abrogation of DKK3 led to reduced tubular atrophy and decreased interstitial matrix accumulation in two mouse models of renal fibrosis. This was facilitated by an amplified, antifibrogenic, inflammatory T cell response and diminished canonical Wnt/beta-catenin signaling in stressed tubular epithelial cells. Moreover, in humans, urinary DKK3 levels specifically correlated with the extent of tubular atrophy and interstitial fibrosis in different glomerular and tubulointerstitial diseases. In summary, our data suggest that DKK3 constitutes an immunosuppressive and a profibrotic epithelial protein that might serve as a potential therapeutic target and diagnostic marker in renal fibrosis. |
